FOLLOWING ECIL 7

FOLLOWING ECIL 7

Vaccination of non-transplanted patients with haematological malignancies: Guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
M MIKULSKA, S CESARO, H DE LA VALLADE, R DI BLASI, S EINARSDOTTIR, G GALLO, C RIEGER, D ENGELHARD, T LEHRNBECHER, P LJUNGMAN, C CORDONNIER
Lancet Infectious Diseases 2019, doi: 10.1016/s1473-3099(18)30601-7

Vaccination of Haematopoietic Stem Cell Transplant Recipients: Guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
C CORDONNIER, S EINARSDOTTIR, S CESARO, R DI BLASI, M MIKULSKA, C RIEGER, H DE LA VALLADE, G GALLO, T LEHRNBECHER, D ENGELHARD, P LJUNGMAN
Lancet Infectious Diseases 2019, doi: 10.1016/s1473-3099(18)30600-5

Guidelines from the 2017 European Conference on Infections in Leukemia for management of HHV-6 infection in patients with hematological malignancies and after hematopoietic stem cell transplantation.
Ward KN, Hill JA, Hubacek P, de la Camara R, Crocchiolo R, Einsele H, Navarro D, Robin C, Cordonnier C, Ljungman P.
Haematologica. 2019 Aug 29. pii: haematol.2019.223073. doi: 10.3324/haematol.2019.223073

download

ECIL guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation
Per Ljungman, Rafael de la Camara, Christine Robin, Roberto Crocchiolo, Hermann Einsele, Joshua A Hill, Petr Hubacek, David Navarro, Catherine Cordonnier, Katherine N Ward on behalf of the 2017 European Conference on Infections in Leukaemia group
Lancet Infectious Diseases 2019, août;19(8):e260-e272. doi: 10.1016/S1473-3099(19)30107-0

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C; European Conference on Infections in Leukemia (ECIL).
J Infect. 2018 Jan;76(1):20-37. doi: 10.1016/j.jinf.2017.10.009. Epub 2017 Oct 25

ECIL guidelines on Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology
Georg Maschmeyer, Julien De Greef, Sibylle C. Mellinghoff, Annamaria Nosari, Anne Thiebaut-Bertrand, Anne Bergeron, Tomas Franquet, Nicole M. A. Blijlevens, Johan A. Maertens (on behalf of the European Conference on Infections in Leukemia (ECIL))
Received: 19 October 2018 / Revised: 31 December 2018 / Accepted: 11 January 2019
© The Author(s) 2019. This article is published with open access

download

The Organizers sincerely thank the following companies for their support of the European Conference on Infections in Leukaemia.
Our partners have had no input into the development of any of meetings or materials.

immy scy olm
leukemia
ichs
eortc
EBMT

Live! by GL events
59 quai Rambaud
CS 80059
69285 LYON CEDEX 02
ecil@gl-events.com
www.livebyglevents.com

Cookies settings

×

Functional Cookies

This site uses cookies to ensure its proper functioning and cannot be disabled from our systems. We do not use them for advertising purposes. If these cookies are blocked, some parts of the site will not be able to function.

Measure of audience

This site uses audience measurement and analysis cookies such as Google Analytics to evaluate and improve our website.

Interactive Content

This site uses third-party components, such as NotAllowedScriptReCAPTCHA V3 which may place cookies on your machine. If you decide to block a component, the content will not be displayed.

Other cookies

This website uses a number of cookies to manage, for example, user sessions.